Agile Therapeutics Company
.jpg)
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women. The company's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
Reproductive Health & Contraception
Investors Number:
11
Last Funding Date:
2021-10-08
Founded Date:
01-01-1997
Headquarters:
Princeton, New Jersey, United States
Total Funding:
$204,471,650
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50